Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.
Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.
Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.
|Since 2020||Partner, Taylor Wessing LLP|
|2015 - 2020||Partner, Penningtons Manches Cooper LLP, Cambridge|
|2010 - 2015||Partner, Paul Hastings LLP, London|
|2002 - 2009||Lawyer, Herbert Smith|
|2018||Admitted as a foreign legal consultant, state bar of California|
|2004||Admitted as a lawyer, England and Wales|
|2001||LPC and Post Graduate Degree in Law, Nottingham Law School|
Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million
The AIM market: guides for US issuers